Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3160-3165

  Hofstra, Julia M ^a   Deegens, Jeroen K J ^a   Steenbergen, Eric J ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fatty acid binding protein; H FABP; L FABP; Membranous nephropathy; Renal outcome

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; KIDNEY BIOPSY; KIDNEY DISTAL TUBULE; KIDNEY FAILURE; KIDNEY PROXIMAL TUBULE; LIVER; MALE; MEMBRANOUS GLOMERULONEPHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEINURIA; URINARY EXCRETION;

ADULT; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES, DISTAL; KIDNEY TUBULES, PROXIMAL; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA;

EID: 52449101633     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn190     Document Type: Article

References (21)

1. D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995; 26: 124-132
2. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456
3. Branten AJW, du Buf-Vereijken PW, Klasen IS et al. Urinary excretion of β2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am Soc Nephrol 2005; 16: 169-174
4. Bazzi C, Petrini C, Rizza V et al. Urinary excretion of IgG and a 1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis 2001; 38: 240-248
5. Bazzi C, Petrini C, Rizza V et al. Urinary N-acetyl-B- glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002; 17: 1890-1896
6. Maatman RG, Kuppevelt van T, Veerkamp JH. Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J 1991; 273: 759-766
7. Kimura H, Fujii H, Suzuki S et al. Lipid-binding proteins in rat and human kidney. Kidney Int Suppl 1999; 71: S159-S162
8. Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006; 374: 1-7
9. Yamamoto T, Noiri E, Ono Y et al. Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 2007; 18: 2894-2902
10. Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
11. Davison AM, Cameron JS, Kerr DN et al. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 1984; 22: 61-67
12. Honkanen E. Survival in idiopathic membranous glomerulonephritis. Clin Nephrol 1986; 25: 122-128
13. Cattran DC, Pei Y, Greenwood C, Ponticelli C, Passerini P, Honkanen E. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 1997; 51: 901-907
14. du Buf-Vereijken PW, Branten AJ, Wetzels JF. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. Nephrol Dial Transplant 2004; 19: 1142-148
15. Pelsers MMAL, Hermens WT, Glatz JFC. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005; 352: 15-35
16. Glatz JFC, Storch J. Unravelling the significance of cellular fatty acid-binding proteins. Curr Opin Lipidol 2001; 12: 267-274
17. Kamijo A, Sugaya T, Hikawa A et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004; 165: 1243-1255
18. Kamijo A, Sugaya T, Hikawa A et al. Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. J Lab Clin Med 2005; 145: 125-133
19. Kamijo A, Sugaya T, Hikawa A et al. Urinary liver-type fatty acid-binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 2006; 284: 175-182
20. Nayashida N, Chihara S, Tamaya E et al. Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery. J Cardiovasc Surg (Torino) 2001; 42: 735-740
21. Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994; 5: 1273-1287